GOLDMAN SACHS GROUP INC - DESIGN THERAPEUTICS INC ownership

DESIGN THERAPEUTICS INC's ticker is DSGN and the CUSIP is 25056L103. A total of 98 filers reported holding DESIGN THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 3.50 and the average weighting 0.2%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of DESIGN THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$1,049,016
-62.8%
444,498
-0.7%
0.00%
-100.0%
Q2 2023$2,818,721
+62.5%
447,416
+48.8%
0.00%
Q1 2023$1,734,601
-38.4%
300,624
+9.5%
0.00%
-100.0%
Q4 2022$2,816,073
-83.0%
274,471
-72.4%
0.00%
-75.0%
Q3 2022$16,614,000
+1201.0%
993,645
+989.1%
0.00%
Q2 2022$1,277,000
-32.5%
91,237
-22.1%
0.00%
Q1 2022$1,892,000
+30.3%
117,132
+72.7%
0.00%
Q4 2021$1,452,000
+79.3%
67,838
+23.0%
0.00%
Q3 2021$810,000
+93.3%
55,134
+161.6%
0.00%
Q2 2021$419,000
-83.2%
21,078
-74.7%
0.00%
-100.0%
Q1 2021$2,495,00083,4500.00%
Other shareholders
DESIGN THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
SR ONE CAPITAL MANAGEMENT, LP 6,526,476$66,961,64424.44%
Cormorant Asset Management, LP 5,150,000$52,8393.54%
Logos Global Management LP 2,797,501$28,702,3603.36%
RA Capital Management 2,971,231$30,484,8300.62%
Ghost Tree Capital, LLC 82,853$850,0000.36%
Avoro Capital Advisors LLC 2,272,222$23,312,9980.35%
EcoR1 Capital, LLC 884,903$9,079,1050.28%
SILVERARC CAPITAL MANAGEMENT, LLC 57,025$585,0770.17%
Ikarian Capital, LLC 48,500$497,6100.12%
Rock Springs Capital Management LP 460,391$4,723,6120.11%
View complete list of DESIGN THERAPEUTICS INC shareholders